- Home
- FTI vs NBIX Comparison
FTI vs NBIX Comparison
Compare FTI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- NBIX
- Stock Information
- Founded
- FTI 1884
- NBIX 1992
- Country
- FTI United States
- NBIX United States
- Employees
- FTI N/A
- NBIX N/A
- Industry
- FTI Metal Fabrications
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTI Industrials
- NBIX Health Care
- Exchange
- FTI Nasdaq
- NBIX Nasdaq
- Market Cap
- FTI 12.7B
- NBIX 13.7B
- IPO Year
- FTI N/A
- NBIX 1996
- Fundamental
- Price
- FTI $32.58
- NBIX $143.26
- Analyst Decision
- FTI Strong Buy
- NBIX Buy
- Analyst Count
- FTI 13
- NBIX 22
- Target Price
- FTI $35.42
- NBIX $164.81
- AVG Volume (30 Days)
- FTI 3.5M
- NBIX 1.0M
- Earning Date
- FTI 02-27-2025
- NBIX 02-05-2025
- Dividend Yield
- FTI 0.61%
- NBIX N/A
- EPS Growth
- FTI N/A
- NBIX 97.40
- EPS
- FTI 1.43
- NBIX 3.73
- Revenue
- FTI $8,796,600,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- FTI $16.28
- NBIX $27.07
- Revenue Next Year
- FTI $9.78
- NBIX $17.14
- P/E Ratio
- FTI $22.72
- NBIX $38.43
- Revenue Growth
- FTI 17.82
- NBIX 25.72
- 52 Week Low
- FTI $18.54
- NBIX $110.95
- 52 Week High
- FTI $33.45
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- FTI 67.09
- NBIX 66.20
- Support Level
- FTI $32.04
- NBIX $138.66
- Resistance Level
- FTI $32.81
- NBIX $144.24
- Average True Range (ATR)
- FTI 0.85
- NBIX 3.23
- MACD
- FTI 0.20
- NBIX 0.07
- Stochastic Oscillator
- FTI 82.03
- NBIX 82.29
About FTI TechnipFMC plc
TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.